1800025-30-2Relevant articles and documents
Optimization of a novel series of N-phenylindoline-5-sulfonamide-based acyl CoA:monoacylglycerol acyltransferase-2 inhibitors: Mitigation of CYP3A4 time-dependent inhibition and phototoxic liabilities
Sato, Kenjiro,Takahagi, Hiroki,Kubo, Osamu,Hidaka, Kousuke,Yoshikawa, Takeshi,Kamaura, Masahiro,Nakakariya, Masanori,Amano, Nobuyuki,Adachi, Ryutaro,Maki, Toshiyuki,Take, Kazumi,Takekawa, Shiro,Kitazaki, Tomoyuki,Maekawa, Tsuyoshi
, p. 4544 - 4560 (2015)
Acyl CoA:monoacylglycerol acyltransferase-2 (MGAT2) has emerged as a potential peripheral target for the treatment of obesity and metabolic disorders. We previously identified a novel series of N-phenylindoline-5-sulfonamide derivatives exemplified by 2 a